About Us
Our Science
Corporate Governance
Investors
Media
Contact
About Us
Purpose, Vision & Mission
CEO corner
Organisation
Management
Board of Directors
Collaborations and partners
Career
Vacant positions
Sustainability / Corporate Responsibility
Our Science
XR-17 Technology Platform
Benefits
Therapeutic focus
IP protection
Commercialized products
Apealea
Project Portfolio
Docetaxel Micellar
XR-19
Animal Health
Research and development
Corporate Governance
Governance reports
General Meeting
Management
Board of Directors
Nomination Committee
Remuneration
Auditor
Code of Conduct
Articles of Association
Investors
Investment case
The Share
Ownership Structure
Financial Reports and Presentations
Analyst coverage
Prospectuses
Archive US listing
SEC Filings
Info regarding delisting of ADS from NASDAQ US
Press releases
Financial calendar
Subscribe
Contact
Media
Press releases
Presentations
Events
Subscribe
Contact
Contact
Analyst coverage
– Thomas Nilsson
– Dr Joseph Hedden
– Dr Susie Jana & Dr John Priestner
We uses cookies in order to optimize your use of our website.
Read more about cookies
.
No, I do not accept cookies
Yes, I accept cookies
